Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Screening Of Genetic Alterations Related To Non-syndromic Hearing Loss Using Massarray Iplex (r) Technology
Author: Costa Melo Svidnicki
Maria Carolina; Silva-Costa
Sueli Matilde; Ramos
Priscila Zonzini; Pereira dos Santos
Nathalia Zocal; Arrojo Martins
Fabio Tadeu; Castilho
Arthur Menino; Sartorato
Edi Lucia
Abstract: Background: Recent advances in molecular genetics have enabled to determine the genetic causes of non-syndromic hearing loss, and more than 100 genes have been related to the phenotype. Due to this extraordinary genetic heterogeneity, a large percentage of patients remain without any molecular diagnosis. This condition imply the need for new methodological strategies in order to detect a greater number of mutations in multiple genes. In this work, we optimized and tested a panel of 86 mutations in 17 different genes screened using a high-throughput genotyping technology to determine the molecular etiology of hearing loss. Methods: The technology used in this work was the MassARRAY iPLEX (R) platform. This technology uses silicon chips and DNA amplification products for accurate genotyping by mass spectrometry of previous reported mutations. The generated results were validated using conventional techniques, as direct sequencing, multiplex PCR and RFLP-PCR. Results: An initial genotyping of control subjects, showed failures in 20 % of the selected alterations. To optimize these results, the failed tests were re-designed and new primers were synthesized. Then, the specificity and sensitivity of the panel demonstrated values above 97 %. Additionally, a group of 180 individuals with NSHL without a molecular diagnosis was screened to test the diagnostic value of our panel, and mutations were identified in 30 % of the cases. In 20 % of the individuals, it was possible to explain the etiology of the HL. Mutations in GJB2 gene were the most prevalent, followed by other mutations in in SLC26A4, CDH23, MT-RNR1, MYO15A, and OTOF genes. Conclusions: The MassARRAY technology has the potential for high-throughput identification of genetic variations. However, we demonstrated that optimization is required to increase the genotyping success and accuracy. The developed panel proved to be efficient and cost-effective, being suitable for applications involving the molecular diagnosis of hearing loss.
Subject: Autosomal-recessive Deafness
Connexin 26 Gene
Genotype-phenotype Correlation
Syndrome Type 1d
Sensorineural Deafness
Auditory Neuropathy
Nonsyndromic Deafness
Missense Mutations
Country: LONDON
Citation: Screening Of Genetic Alterations Related To Non-syndromic Hearing Loss Using Massarray Iplex (r) Technology. Biomed Central Ltd, v. 16, p. SEP-2015.
Rights: aberto
Identifier DOI: 10.1186/s12881-015-0232-8
Date Issue: 2015
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
wos_000361720800001.pdf868.55 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.